Stimuli Responsive-Nano-drug Targeting for Cancer Treatment and Theranostics
Oct 2025 · Academic Press
Ebook
350
Pages
family_home
Eligible
info
infoThis book will become available on October 1, 2025. You will not be charged until it is released.
About this ebook
Stimuli Responsive-Nano-drug Targeting for Cancer Treatment and Theranostics is a groundbreaking book that offers cutting-edge insights into the role of nanotechnology in cancer therapy. This book serves as a bridge between theoretical concepts and rigorous investigations, focusing on material carriers for chemotherapeutic drugs. It emphasizes structural features and targeted approaches that enhance therapeutic efficacy. The book comprises 18 chapters that delve into nanocarriers in cancer research, cancer therapies, and the application of Artificial Intelligence in stimuli responsive-Nano-drug targeting. Each chapter includes illustrative examples, making it a valuable resource for health professionals, scientists, researchers, practitioners, and students. - Delves into the topic of material carriers for chemotherapeutic drugs, specifically focusing on the structural features and targeted approaches that enhance therapeutic efficacy - Discusses the metabolic pathways that are activated by drug-loaded NCs - Examines the progress of drug delivery systems that can respond to stimuli
About the author
Mohammad Amjad Kamal is Distinguished Adjunct Professor at King Fahd Medical Research Center, King Abdulaziz University, Saudi Arabia. Professor Kamal's overall biochemical research output has culminated in more than 600 publications in journals of international repute and 61 abstracts in international conferences. His research was pivotal in supporting the development of the novel anti-Alzheimer agents from the laboratory to the clinic via collaboration with Dr Nigel H. Greig (United States). He migrated to Australia in 1998 and was awarded a prestigious U2000 Postdoctoral Fellowship in 2000 by the University of Sydney, School of Molecular and Microbial Biosciences.Arun Kumar Singh earned his M. Pharm in Pharmaceutics from Galgotias University and currently serves as an Assistant Professor at the Amity Institute of Pharmacy, Amity University, Greater Noida. With over a decade of experience teaching pharmacology-related courses, Professor Singh has cultivated a diverse range of research interests, including nano-formulation, blockchain, IoT, machine learning, cancer, artificial intelligence, big data, and neuroscience. He has authored 5 book chapters, edited multiple books with notable international publishers, and has published 24 review papers, including two in the prestigious Biochimica et Biophysica Acta (BBA) – Reviews on Cancer. Renowned for his research acumen, innovative thinking, leadership, and positive outlook, Professor Singh's dedication and hard work have distinguished him as a leading figure in his field.Dr. Hitesh Chopra, PhD currently at Saveetha School of Engineering is working in primarily area of interest includes nanoformulations, natural polymers, cancer, and wound healing and metabolic disorders. He has authored several papers in high-repute journals with total impact factor more than 1000Arya Rai, MPharm, is affiliated with the Department of Pharmacy, Chitkara College of Pharmacy. Her areas of interest include nanoformulation, cocrystal, blockchain, IoT, machine learning, cancer, artificial intelligence. She has two books' chapters with different publishers. She has also published several artiles and 2 chapters in high impact factors journals.
Reading information
Smartphones and tablets
Install the Google Play Books app for Android and iPad/iPhone. It syncs automatically with your account and allows you to read online or offline wherever you are.
Laptops and computers
You can listen to audiobooks purchased on Google Play using your computer's web browser.
eReaders and other devices
To read on e-ink devices like Kobo eReaders, you'll need to download a file and transfer it to your device. Follow the detailed Help Center instructions to transfer the files to supported eReaders.
